Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

15.4%

2 terminated out of 13 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

15%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

67% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (5)
P 3 (1)
P 4 (1)

Trial Status

Completed4
Recruiting3
Unknown3
Terminated2
Active Not Recruiting1

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (13)

Research Network

Activity Timeline